Injectables, Lasers and Korea's Medical-Beauty Tourism — 2026-09-12
South Korea’s medical tourism sector recorded explosive growth in dermatology patient volumes, with foreign patients in the specialty surging nearly 450% since 2023. A major data breach affecting the popular "Gangnam Onni" booking platform exposed the personal information of over 220,000 users, including tens of thousands of Japanese visitors, raising immediate privacy concerns. Meanwhile, the FDA issued fresh alerts regarding counterfeit botulinum toxin products, urging clinicians to verify supply chain integrity.
Injectables, Lasers and Korea's Medical-Beauty Tourism — 2026-09-12
Top developments
Foreign Dermatology Patients Surge 449% Since 2023
According to recent analysis by Travie citing Korea Health Industry Development Institute (KHIDI) data, the number of foreign patients receiving dermatology treatments in South Korea rose from 239,060 in 2023 to 1,312,700 in 2025, a 449.1% increase. This growth significantly outpaced plastic surgery, which saw a 104.3% rise, and internal medicine, which grew by 113.5%. The data underscores a structural shift in medical tourism where non-invasive skin treatments and injectables have become the primary draw for international visitors, moving beyond traditional surgical procedures.
Data Breach at "Gangnam Onni" Exposes 220,000 Users
On September 7, the operator of the Korean beauty medical platform "Gangnam Onni" announced that unauthorized access to their system occurred on September 4. Approximately 220,000 individuals’ personal information was leaked, including details for about 48,000 Japanese users. This incident highlights significant cybersecurity risks for platforms facilitating cross-border aesthetic treatments, potentially impacting trust among key demographics like Japanese tourists who frequently use such services for booking consultations.
FDA Issues New Guidelines on Counterfeit Botox
The U.S. Food and Drug Administration (FDA) has released updated guidelines for dermatology clinicians to help identify counterfeit botulinum toxin products. As demand for injectables rises globally, the proliferation of fake Botox has drawn increased federal scrutiny. Clinicians are advised to verify packaging features and supply chain integrity, as counterfeit products may contain unknown ingredients posing serious health risks, including botulism-related adverse events.
Seoul Medical Travel Mart Targets 2 Million Foreign Patients
The "2026 Seoul Medical Tourism International Travel Mart," hosted by the Seoul Metropolitan Government and Seoul Tourism Organization, took place on September 8–9. Now in its eighth year, the event brought together around 70 overseas buyers to discuss strategies for attracting more international patients. The initiative aims to capitalize on the rapid growth of dermatology and aesthetic services, positioning Seoul as a hub for high-volume, high-quality medical tourism.
Local view
Travel Times (Korea) reports that the Seoul government is aggressively targeting the 2 million foreign patient milestone, with the recent travel mart serving as a key networking venue for clinics and international agencies. The outlet highlights the competitive pressure on local clinics to differentiate themselves through specialized dermatological offerings rather than just surgical procedures.
Asahi Shimbun (Japan) focuses heavily on the security implications of the Gangnam Onni breach, warning Japanese consumers who frequently book Korean aesthetic treatments via this platform to monitor their accounts for suspicious activity. The report notes that leaked items included names, email addresses, and potentially other personal details used for booking.
Vegan News (Korea) published guidance for consumers considering "skin booster" injections, emphasizing that these are not a single standardized product but vary widely in ingredients and application methods. The article advises patients to verify specific product names and clinical data before undergoing treatment, reflecting growing consumer awareness of product variability in the Korean market.
Context & numbers
- Dermatology Growth: Foreign dermatology patients increased from 239,060 (2023) to 1,312,700 (2025), a +449.1% change.
- Plastic Surgery Growth: Foreign plastic surgery patients increased from 114,074 (2023) to 233,100 (2025), a +104.3% change.
- Data Breach Scale: Approximately 220,000 users affected, including ~48,000 Japanese nationals.
- FDA Warning Letters: The FDA recently sent warning letters to 18 websites selling counterfeit or unapproved Botox products.
On the radar
- Security Audits: Following the Gangnam Onni breach, other major Korean medical tourism platforms may face increased scrutiny and calls for stricter cybersecurity audits from both Korean and Japanese regulatory bodies.
- Counterfeit Enforcement: Expect continued FDA actions against online sellers of unapproved injectables, which may impact the cross-border sale of certain Korean brand toxins if they are not properly FDA-cleared for the U.S. market.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
